Engineered antibodies directed against a promising therapeutic target on ovarian cancer cells
Tuesday, April 20, 2010 - 06:21
in Health & Medicine
Stealthy and stubborn, ovarian cancer is a particularly vexing malignancy, difficult to diagnose in early stages and difficult to treat once it progresses further. However, research at Fox Chase Cancer Centre is now focusing on one of the most promising new approaches to dealing with the disease - using engineered antibodies to target tumour cells while leaving healthy cells intact...